In summary, we have demonstrated via in-depth mechanistic studies that DuoBody-CD3x5T4 efficiently induces T cell–mediated cytotoxicity of 5T4+ tumor cells and bystander kill of 5T4− tumor cells. Here, TPBG is linked to neoplasm.